WAVE Life Sciences Ltd to Discuss the FOCUS-C9 Clinical Trial Update Investor Call Transcript
Good morning, and welcome to the Wave Life Sciences FOCUS-C9 Clinical Trial Update Conference Call. (Operator Instructions) As a reminder, this call is being recorded and webcast.
I'll now turn the call over to Kate Rausch, Head of Investor Relations at Wave Life Sciences. Please go ahead.
Thank you, operator. Good morning, and thank you for joining us today. This morning, we issued a news release providing an update on our FOCUS-C9 Clinical Trial. For those participating via conference call, we have made slides available via webcast. A replay of this call will also be available in the Investors section of our website following the call.
Joining me in the room today with prepared remarks are Dr. Paul Bolno, Wave's President and Chief Executive Officer; Dr. Mike Panzara, Chief Medical Officer, Head of Therapeutics Discovery and Development; and calling in from AAN in Seattle, Dr. Merit Cudkowicz, Chief of MGH Hospital, Neurology Service and Professor of Neurology at Harvard Medical School.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |